Skip to main content
Loading ResearchHub…
References for Part 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injections | ResearchHub - ResearchHub